Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| RC-008-060-510 | 060-5101 | South Africa | 2000 | HIV1 | C | Plasma | None |
Treatment History
| Order | Regimen | Weeks |
| 1 | ATV+D4T+3TC | NA |
Protease Sequence
| PIMajorDRMs | PIMinorDRMs | Polys | UnusualMuts |
| I50L | L89MV | T12S, I15V, G16GE, L19I, K20KT, E35ED, M36I, R41K, K45R, D60E, L63LP, I64IV, H69K, A71AV, I85IV, I93L |
| >060-5101| codons 1-99 PQITLWQRPLVSIKVEGQITEALLDTGADDTVLEDINLPGKWKPRMIGGLGGFIKVRQYE QIPVEICGKKVIGTVLVGPTPVNIVGRNVLTQLGCTLNF |
References
| Author | Title | Citation |
| Colonno, RJ | Identification of I50L as the signature atazanavir (ATV)-resistance mutation in treatment-naive HIV-1-infected patients receiving ATV-containing regimens. | J Infect Dis, 2004 |